Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Canada
Canada: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 85.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Canada, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Canada is 85.0%, measured in 2025. That is the highest value across all 18 years on record.
That represents a change of up 6.2% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Canada peaked at 85.0% in 2022 and was at its lowest, 42.0%, in 2008.
That places Canada 96th out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 46.0% | 42.0% | 50.0% | 2 |
| 2010s | 76.1% | 58.0% | 84.0% | 10 |
| 2020s | 84.7% | 84.0% | 85.0% | 6 |
Countries ranked near Canada
More health data for Canada
- Un projection of annual infant deaths 385 (2100)
- Heat deaths vs projected death rates 1,083 (2090)
- Deaths in armed conflicts by region 0 (2026)
- Deaths in armed conflicts by country 0 (2026)
- Age population, age 14, male, interpolated 217,399 (2025)
- Age population, age 16, male, interpolated 222,925 (2025)
- Age population, age 16, female, interpolated 215,145 (2025)
- Population ages 15-64, total 26.97 million (2025)
- Age population, age 15, male, interpolated 220,012 (2025)
- Age population, age 15, female, interpolated 211,687 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Canada?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Canada was 85.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Canada?
- The highest recorded value was 85.0% in 2022.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Canada?
- The lowest recorded value was 42.0% in 2008.
- How does Canada rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Canada ranks 96th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Canada?
- Over the last ten years it is up 6.2%. The long-run trend across the full record is rising.
- Where does this Canada data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).